arBtrage CAPITALIZING MARKETS checking… Sign in

Grace Therapeutics, Inc.

GRCE Health Care Biotechnology: Pharmaceutical Preparations
$2.30
▼ -3.8% Today
as of Jun 7, 06:45 ET
Last 30 days +9.52% Apr 28 → Jun 05
$2.05 $2.22 $2.39 $2.57 $2.74 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$2.38
High
$2.52
Low
$2.26
Volume
$286,083
Avg Vol
$263,143
Mkt Cap
$32M
P/E (TTM)
Beta
52w High
$5.18
52w Low
$1.79
Div Yield
Shares Out
$15M

Overview

52-week range
$1.79
$5.18
15% of range
Avg surprise (last 1)
-5.0%
Avg reaction (last 1)
-2.3%
0% positive
Latest IV / EM
78%
EM ±10.9% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.54$-0.42$-0.30$-0.18$-0.06 Actual $-0.54Actual $-0.43Actual $-0.21Actual $-0.24Actual $-0.30Actual $-0.36Actual $-0.21Est $-0.20Actual $-0.06Actual $-0.14 JunSepDecJunSepDecMar/2025SepDec
Revenue vs Net Income Revenue Net income
$-4M$-3M$-3M$-2M$-984,900 Jun 24Sep 24Dec 24Jun 25Sep 25Dec 25

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Dec 31, 2025Dec 2025 $-0.14 financials
Tue Sep 30, 2025Sep 2025 $-0.06 financials
Mon Jun 23, 2025Mar/2025 $-0.21 $-0.20 -5.0% -2.3% earnings
Tue Dec 31, 2024Dec 2024 $-0.36 financials
Mon Sep 30, 2024Sep 2024 $-0.30 financials
Sun Jun 30, 2024Jun 2024 $-0.24 financials
Sun Dec 31, 2023Dec 2023 $-0.21 financials
Sat Sep 30, 2023Sep 2023 $-0.43 financials
Fri Jun 30, 2023Jun 2023 $-0.54 financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Mon Jun 22, 2026Mar/2026OTHER -$0.24-$0.21 -14.3%

Financials

Income statement (quarterly)

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
Cost of revenue
Gross profit
Operating income$-2M$-3M$-3M$-4M$-5M$-5M
Net income$-2M$-938,000$-3M$-4M$-3M$-3M
EPS (diluted)$-0.14$-0.06$-0.21$-0.36$-0.30$-0.24

Balance sheet (quarterly)

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Cash & equivalents$19M$17M$20M$22M$11M$15M$19M$23M
Inventory
Total current assets$19M$17M$21M$23M$12M$16M$20M$24M
Total assets$68M$67M$70M$72M$61M$65M$70M$73M
Long-term debt
Total liabilities$4M$4M$6M$5M$9M$9M$10M$12M
Total equity$65M$63M$64M$67M$52M$56M$59M$62M

Implied volatility — last 90 days

71%74%77%80%83% Jun 06 — IV 77% · EM ±13.6%Jun 07 — IV 78% · EM ±10.9%

Sector peers